generated: '2026-08-25'
method: searched
source: https://mbracetrx.com/ full site walk 2026-08-25 (sitemap_index.xml + all 12 published pages)
note: >-
  MBrace Therapeutics publishes no API plans, no pricing page, no free tier, no enterprise tier and
  no "contact sales" flow for API access — because it sells no API. It is a clinical-stage
  biopharmaceutical company; its commercial surface is drug development, not software. The content
  API catalogued in this repo is an unpriced, unmetered, unadvertised side effect of its marketing
  CMS, available anonymously to anyone.
plan_count: 0
plans: []
pricing_page: null
free_tier:
  exists: false
  detail: >-
    Not applicable. There is no account, no signup, no key and therefore no tier. Every catalogued
    operation is anonymously readable at no cost.
commercial_model:
  api_monetized: false
  signup_required: false
  detail: >-
    No /pricing, /plans, /developer or /signup page exists on mbracetrx.com — the published page set
    is Home, About Us, Pipeline, Discovery Platform, the MBRC-101 and MBRC-201 programme pages,
    Expanded Access Statement, Contact, Terms of Use and Privacy Policy. The company's disclosed
    capital is investment rather than API revenue: an $85M Series B led by TPG (announced November
    2023) on top of a Series A, for $110M total raised.
pages_probed:
- url: https://mbracetrx.com/
  status: 200
- url: https://mbracetrx.com/contact/
  status: 200
- url: https://mbracetrx.com/pipeline/
  status: 200